glp-1 kidney outcomes news Human, exendin-based receptor agonists similarly reduce CV, renal risk in diabetes GLP-1s lower BMI, preserve kidney

PMID: 48 QuastDRSchenkerNMengeBANauckMAKapitzaCMeierJJ

The mechanisms for these include: decreased fibrinolytic activity in vessel walls, increased oxidative stress in endothelial cells, and possibly increased intracellular calcium in vascular smooth muscle cells (161, 162, 192)

Fewer than half of employer plans cover weight-loss drugs Wegovy and Ozempic are glucagon-like peptide-1 drugs, or GLP-1s, that suppress the appetite of users, leading to weight loss

10.1309/AJCPGPMAF7SFRBO4 24 DhayatN

As group vice president at Lilly, DiMarchi generated rDNA-derived medicines that dramatically advanced the treatment of Type 1 and Type 2 diabetes

Li L, Ng SR, Coln CI, Drapkin BJ, Hsu PP, Li Z, et al